From an immune perspective, the high proportions of CD8+ T and Tfh cells and low proportion of Th17 cells may be the reasons for the favorable survival time in the group of HNSCC patients with high PRAS40 expression. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.